RTTNews | Nov 9, 2020 08:24AM EST

08:24 Monday, November 9, 2020 (RTTNews) - I-Mab Reports Phase 1 Trial Data Of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved